Immunodiagnostic Systems Holdings PLC provided unaudited group revenue guidance for the six months ended 30 September 2019 and fiscal year 2020. For the period, the company expects group revenues to be £18.8 million. On a like for like basis, that is at constant exchange rate and scope, Group revenues are in line with the same period last year. Based on the positive momentum within first half of 2020 the company maintain the company's fiscal year 2020 target of delivering increased full year revenue on a LFL basis versus fiscal year 2019.